DIR Return Create A Forum - Home
---------------------------------------------------------
Camelot Fantasies
HTML https://castleknights.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: PENNY STOCK UNIVERSE
*****************************************************
#Post#: 13531--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 11, 2014, 8:55 am
---------------------------------------------------------
another rough day in the markets and in the cannabis space but
there seems to be some recovery in the process now.
ATTBF is trying to hold its ground now and stage a recovery.
#Post#: 13547--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 11, 2014, 10:20 pm
---------------------------------------------------------
well no recovery possible on a day when the markets went to hell
in a hand basket again.
biotechs and cannabis sector stocks got hit pretty hard.
this creates a lot of opportunities for next week.
#Post#: 13549--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 11, 2014, 11:27 pm
---------------------------------------------------------
top story on cannabis financial news:
HTML http://www.cannabisfn.com/abattis-gains-potential-exposure-to-mmpr-via-subsidiary-share-exchange/#.U0jAL2dOWpo
#Post#: 13563--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 12, 2014, 9:09 am
---------------------------------------------------------
Abattis Gains Potential Exposure to MMPR via Subsidiary Share
Exchange
 Ryan Allway
📅 April 11th, 2014
 Feature Stories
7
Abattis Bioceuticals Corp. (OTC: ATTBF), a specialty
biotechnology company focused on cultivating, licensing, and
marketing proprietary ingredients, bio-similar compounds,
patented equipment, and consulting services to medicinal
marijuana markets in North America, recently announced a share
exchange agreement between its Northern Vine subsidiary and
Experion Biotechnologies Inc.
Under the fair and equal value exchange agreement, Abattis
Bioceuticals gained a 25% stake in Experion – who is in the late
stages of an MMPR application to become a Licensed Producer in
Canada – by trading a 25% stake in its privately-held subsidiary
Northern Vine. The move adds to the “Grow” component of Abattis
Bioceuticals GDERS (“Grow, Dry, Extract, Refine, Science/Sell”)
business model.
Canada transitioned from its old Marihuana Medical Access
Regulations (“MMAR”) to Marihuana for Medical Purposes
Regulations (“MMPR”) on April 1, 2014. The move will force
40,000 Canadian medical marijuana users to begin purchasing
product from Licensed Producers rather than from the government
or growing it on their own in their homes in order to tighten
the market’s regulation.
The MMPR will also greatly expand access to the drug for medical
purposes. In fact, Health Canada expects the number of medical
marijuana users to grow to 450,000 with the market reaching $1.3
billion in size by 2024. There are only 12 approved Licensed
Producers right now with approximately 450 outstanding
applications, although the barriers to entry are very high
leading to many denials.
“This is a strategic partnership that links our pending
Controlled Substance License to another MMPR Application in
order to further expand our business potential,” said Abattis
Bioceuticals President and CEO Mike Withrow. “This agreement
provides the company with more control of a broader variety of
raw materials, for products derived from marijuana, to be
processed at our planned botanical facility in Quebec. This
partnership also creates synergy by joining cultivation with
formulation sciences.”
#Post#: 13584--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 12, 2014, 6:38 pm
---------------------------------------------------------
HTML http://finance.yahoo.com/news/tranzbyte-attbf-sign-letters-intent-140000955.html
Tranzbyte and ATTBF Sign Letters of Intent Creating Strategic
Production, Sales, and Distribution Partnership
.
Marketwired
Tranzbyte Corporation
March 21, 2014 10:00 AM
TEMPE, AZ--(Marketwired - Mar 21, 2014) - Tranzbyte Corporation
(OTC Pink: ERBB)(PINKSHEETS: ERBB)
(
HTML http://www.bloomberg.com/quote/ERBB:US)
announced today that it
has signed a Letter of Intent to form a strategic partnership
with Abattis (OTC Pink: ATTBF)(PINKSHEETS: ATTBF) (CSE: ATT)
(
HTML http://www.bloomberg.com/quote/ATTBF:US)
to sell, market or
otherwise license one another's products in their respective
regions. Once the arrangement is completed, Tranzbyte will have
access to Abattis's expanding suite of bio-ceutical grow
products found in the Biocube Green Grow Systems for cultivation
(LED's, Nutrients - Natures Juice). In addition Abattis owns
proprietary flash freeze extraction technology, which produces
high-grade cannabis and other botanical extracts. Conversely,
Abattis will have the Canadian rights to distribute ZaZZZ™ and
will pair Tranzbyte's Jurassic O2 water systems with its Biocube
Green Grow Systems sales efforts in the US.
"When one looks at the obvious NAFTA synergy, this relationship
makes all the sense in the world. Abattis is a powerhouse in
Canada; we are stronger in the US. From cross-promotion to
extended sales and marketing, the opportunities that will be
created with the two companies working together will be nothing
short of phenomenal," says Stephen Shearin, Tranzbyte COO.
According to David Gwyther, Tranzbyte's president, "I am very
impressed with Abattis's commitment to the research,
development, and marketing capability they've shown involving
their proprietary, natural health and wellness solutions which
address chronic illnesses through targeted nutritional support
and, thus, fit perfectly into Tranzbyte's future plans. Working
together leverages our collective visions for this vast and
expanding marketplace."
In addition, Abattis owns flash-freeze extraction technology
that produces the highest grade flower extract which is in high
demand today. Conventional extraction methods require heat and
solvents which can increase liabilities for dispensaries who
extract on-site. The Northern Vine cold press extraction owned
by Abattis is exactly what the industry needs to fulfill patient
orders in a clean safe manner. "This offers dispensaries and
growers a complete end-to-end solution of cutting-edge grow
technologies and plant analysis," comments Mike Withrow, CEO of
Abattis. "In addition, with the rights to the ZaZZZ™ automated
vending opportunity as the regulatory climate evolves in Canada,
we open up a lot of growth potential. Merging the efforts of the
leading companies in each country should build real shareholder
value for each company."
In other news, the medical and social marijuana division,
formally, Altitude Organix, is changing to American Green™. The
company has purchased both domain and trademark rights to the
name. Its new logo (below) has been designed to evoke a time
before prohibition, when hard working people had more leeway in
their choice of medicine and their pursuit of happiness.
American Green™ is carrying on the American Dream.
Tranzbyte encourages all folks wishing to follow the progress of
Tranzbyte, Altitude Organix, and its other subsidiaries and
divisions to visit the Tranzbyte website at www.tranzbyte.com
and sign up to receive our 'Email Alerts' which are sparingly
sent to interest-holders periodically. Just click on the orange
'contact' button after arriving at the company's website. Mobile
users can also sign up by navigating to the company's website on
their android smart phone or iPhone."
Also, shareholder and other interest-holders may track the
progress of the pending delivery of our fully automated ZaZZZ™
Machine by following us on Twitter @Tranzbyte or
@American__Green (two underscores.)
ABOUT TRANZBYTE
The Tranzbyte Corporation (www.tranzbyte.com) is a driving force
behind Altitude Organix, American Green, OneBode, The YO! Debit
Card, and BancoLibre. The company expects to continue its plan
to acquire, hold, or spin out successful divisions in what has
been described in previous news releases as "dividend farming,"
Companies that qualify and decide to become public on their own
will agree to carve out shares for Tranzbyte and dividends for
their ERBB shareholders.
Tranzbyte also houses the company's 10-year-old technology
division which is actively engaged in the sale of its optical
media enhancement products to potential customers in the US and
Asia. Products in the Tranzbyte division include FLASHAlbum™ and
FlixStix -- technologies that the company plans to be
incorporated into the Company's ZaZZZ Machine while enabling
distributors of optical media (CDs, DVDs, etc.) to consolidate
the best features of each medium onto a single content-protected
USB flash drive.
ABOUT ABATTIS BIOCEUTICALS CORP.
Abattis is a specialty biotechnology company with capabilities
through its wholly owned subsidiaries of cultivating, licensing
and marketing proprietary ingredients, bio-similar compounds,
patented equipment and consulting services to medicinal markets
in North America. The company is positioned to capitalize on the
fast growing trend toward marijuana legalization in the United
States and for medicinal use in Canada and international
jurisdictions by supplying and partnering with companies to
employ its vertical cultivation systems, extraction
equipment/technology, and strategic marketing support to
licensed growers. The company also has an extensive pipeline of
high-quality products and Intellectual Property for the rapidly
expanding botanical drug market. We follow strict Standard
Operating Protocols and adhere to the Law's of Canada and
Foreign Jurisdictions. For more information, visit the Company's
website at www.abattis.com.
#Post#: 13585--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 12, 2014, 8:14 pm
---------------------------------------------------------
take a look at this article. this is huge for ATTBF and for
ERBB.
HTML http://www.thecannabist.co/2014/04/11/direct-access-pot-vending-machines-debut-colorado-next-week/9348/
#Post#: 13586--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 12, 2014, 8:36 pm
---------------------------------------------------------
some experts are rating ATTBF the single best stock to own.
I will post those articles here as soon as I can find them. stay
tuned.
#Post#: 13590--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 13, 2014, 8:03 am
---------------------------------------------------------
here is an interview with the CEO of Abattis:
HTML http://www.cannabisfn.com/mdc/abattis-bioceuticals-corp/
#Post#: 13591--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 13, 2014, 8:06 am
---------------------------------------------------------
another great read on Abattis:
HTML http://www.cannabisfn.com/investors-seek-first-mover-advantage-in-cannabis-market/#.U0qLmWdOWpo
#Post#: 13592--------------------------------------------------
Re: Welcome To The Abbatis Bioceuticals Royal Hall
By: Clay Death Date: April 13, 2014, 8:12 am
---------------------------------------------------------
here is an expert opnion on Abattis:
ATT:CNX; ATTBF:OTC
Shares Outstanding… 47.6M
Market Cap… $88.5M
Abattis remains a top pick out on the West Coast in the Medical
Marijuana scene. I have ATT/ATTBF firmly entrenched in the MMJ
sector and expect Abattis to follow a track similar to PLPL.
Yes I have said PLPL is a top recreation pick, but PLPL is one
of the few companies that I think will transcend both recreation
and medical cannabis. Abattis has methodically developed a
plan of attack and is now executing on that plan.
•Received their controlled substances licence which allows them
to develop extracts, concentrates and oils from the cannabis
they grow.
•Expanded into the US markets developing strategic alliances
with companies like Transbyte ERBB
•Owns arguably the top one of the top vegetable concentration
technologies which can be readily applied to cannabis.
•Own Vertical Designs, a patented vertical growing technology
they plan on licencing to other growers. Vertical Designs
growing technology maximizes space and light efficiencies
allowing for the greatest yields of indoor hydroponics systems.
Abattis has emerged as the market leader out west and is
entrenching themselves as one of the top medical cannabis
companies in North America, let alone Canada.
HTML http://www.beatthemarketstockpicks.com/2014/04/5-canadian-cannabis-companies.html?m=1
*****************************************************
DIR Next Page